4512.T Wakamoto Pharmaceutical JPX 06 Feb 2026: volume 383,200 signals momentum

We saw a clear intraday volume spike in 4512.T stock as Wakamoto Pharmaceutical (JPX) jumped to 330.00 JPY, up 20.00 JPY (6.45%), on 06 Feb 2026. Trading volume reached 383,200 shares versus an average of 56,026, giving a relative volume of 37.25. We flag this as a volume-driven momentum move that traders can monitor for follow-through or quick profit-taking.

Intraday price and volume summary for 4512.T stock

Today Wakamoto Pharmaceutical (4512.T) opened at 334.00 JPY and traded between 326.00 JPY and 337.00 JPY intraday, closing near 330.00 JPY at the time of the snapshot. Volume hit 383,200 shares compared with an average of 56,026. The stock’s one-day change was +20.00 JPY (6.45%). This spike pushed the stock above its 50-day average (294.14 JPY) and 200-day average (298.61 JPY), signalling momentum on JPX.

Drivers and news flow behind the 4512.T stock volume spike

We found no company press release linked directly to today’s move. The next earnings announcement is scheduled for 13 May 2026, which can lift speculative flows. Retail interest likely amplified price action given the high relative volume. For company details see the Wakamoto site and JPX listing: Wakamoto Pharmaceutical and JPX.

Technical read and trading signals for 4512.T stock

Momentum indicators show strength but rising short-term risk. RSI is 72.63 (overbought). MACD histogram is positive (MACD 3.90, Signal 2.22). ADX at 25.33 points to a strong trending day. Price sits above the 50- and 200-day averages, and on-balance volume rose sharply. Traders should watch 337.00 JPY as today’s high and support near 326.00 JPY for intraday setups.

Fundamentals and valuation context for 4512.T stock

Wakamoto reports EPS 2.08 JPY and a high trailing PE at 163.94, reflecting low earnings and a relatively small float. Book value per share is 333.90 JPY, giving a P/B near 1.02. Market cap stands at 11,834,741,908 JPY. Cash per share is 55.10 JPY and dividend per share is 3.00 JPY. The company sits in Healthcare, where sector average PE is ~23.49, so valuation is mixed versus peers.

Meyka AI grade, forecast and price targets for 4512.T stock

Meyka AI rates 4512.T with a score out of 100: 68.89 (Grade B, HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, metrics, forecasts and analyst consensus. Meyka AI’s forecast model projects a near-term quarterly target of 365.58 JPY, a monthly target of 400.11 JPY, and a one-year model of 233.68 JPY. Compared with the current 330.00 JPY, the quarterly target implies an upside of 10.78%. Forecasts are model-based projections and not guarantees.

Risks, liquidity and a volume-spike trading strategy for 4512.T stock

Risks include the high PE (163.94), seasonal demand swings, and concentrated retail flows that can push fast reversals. Liquidity improved today with 383,200 shares, but average volume remains lower at 56,026, so price gaps can occur. For intraday traders we suggest tight stops, scale-in limits, and a plan to exit on declining volume or RSI above 75.

Final Thoughts

Today’s intraday move in 4512.T stock is driven by a pronounced volume spike to 383,200 shares and a price move to 330.00 JPY. Technicals show momentum, but RSI and volume concentration warn of short-term pullbacks. Our model projects a near-term quarterly target of 365.58 JPY, an implied upside of 10.78% versus the current price. Meyka AI’s grade of 68.89 (B, HOLD) reflects mixed fundamentals and sector context. Traders should treat today as a momentum signal, confirm with follow-through volume, and size positions given the elevated PE and retail-driven flows. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.